186 related articles for article (PubMed ID: 25806230)
1. The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.
Karachaliou N; Rosell R; Viteri S
Transl Lung Cancer Res; 2013 Jun; 2(3):172-9. PubMed ID: 25806230
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
3. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
4. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
5. Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.
McCaughan F; Pole JC; Bankier AT; Konfortov BA; Carroll B; Falzon M; Rabbitts TH; George PJ; Dear PH; Rabbitts PH
Am J Respir Crit Care Med; 2010 Jul; 182(1):83-91. PubMed ID: 20299530
[TBL] [Abstract][Full Text] [Related]
6. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
7. SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis.
Swain N; Thakur M; Pathak J; Swain B
J Oral Maxillofac Pathol; 2020; 24(2):368-373. PubMed ID: 33456249
[TBL] [Abstract][Full Text] [Related]
8. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
Fong H; Hohenstein KA; Donovan PJ
Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.
Sodja E; Rijavec M; Koren A; Sadikov A; Korošec P; Cufer T
Radiol Oncol; 2016 Jun; 50(2):188-96. PubMed ID: 27247551
[TBL] [Abstract][Full Text] [Related]
10. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
Ooki A; Dinalankara W; Marchionni L; Tsay JJ; Goparaju C; Maleki Z; Rom WN; Pass HI; Hoque MO
Oncogene; 2018 Nov; 37(45):5967-5981. PubMed ID: 29980786
[TBL] [Abstract][Full Text] [Related]
11. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
12. OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor.
Zhang S; Bell E; Zhi H; Brown S; Imran SAM; Azuara V; Cui W
Stem Cell Res Ther; 2019 Apr; 10(1):122. PubMed ID: 30999923
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cell Subpopulations Are Present Within Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.
Kilmister EJ; Patel J; van Schaijik B; Bockett N; Brasch HD; Paterson E; Sim D; Davis PF; Roth IM; Itinteang T; Tan ST
Front Oncol; 2020; 10():1091. PubMed ID: 32850316
[TBL] [Abstract][Full Text] [Related]
15. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.
Chou YT; Lee CC; Hsiao SH; Lin SE; Lin SC; Chung CH; Chung CH; Kao YR; Wang YH; Chen CT; Wei YH; Wu CW
Stem Cells; 2013 Dec; 31(12):2607-19. PubMed ID: 23940081
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma.
Yu HH; Featherston T; Tan ST; Chibnall AM; Brasch HD; Davis PF; Itinteang T
Front Surg; 2016; 3():46. PubMed ID: 27532037
[TBL] [Abstract][Full Text] [Related]
18. The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells.
Fong YW; Ho JJ; Inouye C; Tjian R
Elife; 2014 Nov; 3():. PubMed ID: 25407680
[TBL] [Abstract][Full Text] [Related]
19. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study.
Masciale V; Grisendi G; Banchelli F; D'Amico R; Maiorana A; Sighinolfi P; Stefani A; Morandi U; Dominici M; Aramini B
Front Oncol; 2019; 9():1394. PubMed ID: 31921651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
